跳至主要内容
临床试验/NCT00168233
NCT00168233已完成不适用

Impact of HIV Infection and Treatment With Highly Active Antiretroviral Therapy on Reverse Cholesterol Transport

The Alfred1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2005年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
44
试验地点
1

研究概览

简要总结

To investigate the effect of treatment of HIV infection with highly active antiretroviral therapy on individual steps of reverse cholesterol transport, endothelial function and intima-media thickness in HIV patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male patients with HIV infection (3 groups of 50 patients each)
  • HIV infected patients, naïve to ARV therapy and not likely to need to commence therapy for the duration of follow-up (12 months)
  • HIV-infected patients, PI naïve, initiating therapy with PI-containing HAART (ARV naïve or NNRTI experienced changing to PI regimen)
  • HIV-infected patients naïve to ARV therapy, initiating NNRTI-containing regimen
  • Exclusion criteria
  • Treatment with any form of lipid lowering drugs, including fish oils.
  • Body Mass Index greater than 27.

排除标准

  • 未提供

研究者

发起方
The Alfred
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jennifer Hoy

Professor Jennifer Hoy

The Alfred

研究点 (1)

Loading locations...

相似试验